4.4 Article

Dosage-dependent requirement for mouse Vezf1 in vascular system development

Journal

DEVELOPMENTAL BIOLOGY
Volume 283, Issue 1, Pages 140-156

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ydbio.2005.04.003

Keywords

Vezfl function; ES cells; knockout mice; endothelial cells; vascular development; angiogenesis; lymphangiogenesis

Funding

  1. NHLBI NIH HHS [R01 HL65738, R01 HL065738] Funding Source: Medline
  2. NICHD NIH HHS [R29 HD31534] Funding Source: Medline
  3. NIDDK NIH HHS [T32 DK07757, T32 DK007757] Funding Source: Medline

Ask authors/readers for more resources

Vezf1 is an early development gene that encodes a zinc finger transcription factor. In the developing embryo, Vezf1 is expressed in the yolk sac mesoderm and the endothelium of the developing vasculature and, in addition, in mesodermal and neuronal tissues. Targeted inactivation of Vezf1 in mice reveals that it acts in a closely regulated, dose-dependent fashion on the development of the blood vascular and lymphatic system. Homozygous mutant embryos display vascular remodeling defects and loss of vascular integrity leading to localized hemorrhaging. Ultrastructural analysis shows defective endothelial cell adhesion and tight junction formation in the mutant vessels. Moreover, in heterozygous embryos, haploinsufficiency is observed that is characterized by lymphatic hypervascularization associated with hemorrhaging and edema in the jugular region; a phenotype reminiscent of the human congenital lymphatic malformation syndrome cystic hygroma. (C) 2005 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available